Search results
Results from the WOW.Com Content Network
Target ranges for hormone levels in hormone therapy for transgender women; Source Place Estradiol, total Testosterone, total Refs Endocrine Society: United States: 100–200 pg/mL <50 ng/dL [1] World Professional Association for Transgender Health (WPATH) United States
A depot injection, also known as a long-acting injectable (LAI), is a term for an injection formulation of a medication which releases slowly over time to permit less frequent administration of a medication.
Testosterone enanthate is used primarily in androgen replacement therapy. [4] [15] It is the most widely used form of testosterone in androgen replacement therapy. [4]The medication is specifically approved, in the United States, for the treatment of hypogonadism in men, delayed puberty in boys, and breast cancer in women. [16]
Reaction at the injection site if you use short-acting testosterone injections. Allergic reaction if you use long-acting injections. Pain and soreness at the injection site. Infections if you use ...
Testosterone can be taken by a variety of different routes of administration. [2] [3] These include oral, buccal, sublingual, intranasal, transdermal (gels, creams, patches, solutions), vaginal (creams, gels, suppositories), rectal (suppositories), by intramuscular or subcutaneous injection (in oil solutions or aqueous suspensions), and as a subcutaneous implant.
While the standard needle size for vaccination is 1 inch, it's recommended that women over 200 lbs. and men over 260 lbs. get shots with 1.5-inch needles. (Getty Images) (Nicolae Toma / 500px via ...
Testosterone is in the androgen family of medications. [9] Testosterone was first isolated in 1935, and approved for medical use in 1939. [12] [13] Rates of use have increased three times in the United States between 2001 and 2011. [14] It is on the World Health Organization's List of Essential Medicines. [15] It is available as a generic ...
Tritiated estradiol radioactivity in blood with a single intramuscular injection of 1.5 to 2.8 μg tritiated estradiol in aqueous solution in four women. [1] Peak blood radioactivity occurred within 15 minutes in three of the women and in the remaining woman after 2 hours. [1] Source: Davis et al. (1963). [1]